A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa

Condition:   Acne Inversa Interventions:   Drug: PF-06650833;   Drug: PF-06700841;   Drug: PF-06826647;   Drug: Placebo Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials